NewAmsterdam Pharma Company N.V. (NAMS)

NAMS Revenue

NewAmsterdam Pharma Company had revenue of $348.00K in the quarter ending September 30, 2025, a decrease of -98.80%. This brings the company's revenue in the last twelve months to $35.24M, up 4.91% year-over-year. In the year 2024, NewAmsterdam Pharma Company had annual revenue of $45.56M with 223.37% growth.

• Revenue (ttm): $35.24M
• Revenue Growth: +4.91%
• P/S Ratio: 109.10
• Revenue / Employee: $457,701
• Employees: 77
• Market Cap: 3.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	45.56M	31.47M	223.37%
Dec 31, 2023	14.09M	-88.60M	-86.28%
Dec 31, 2022	102.69M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-